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Background: Echinostomiasis is one of the major food-borne trematodiases and the species Echinostoma caproni
serves as a useful model for trematocidal drug discovery. The current in vitro drug sensitivity assay uses adult
E. caproni worms that are incubated with candidate drugs and scored microscopically for viability at 72 hrs. The aim
of this study was to investigate the use of newly excysted larvae (NEL) of E. caproni for in vitro drug testing, which
would be faster, more cost effective and more ethical compared to adult worm assays.
Methods: Larvae were obtained by collecting metacercariae from snails and triggering their excystation using the
trypsin-bile salt excystation method. Studies concerning various parameters of this chemical transformation process
as well as appropriate NEL culturing conditions were carried out and findings evaluated. NEL and adult worms were
incubated with praziquantel, tribendimidine, albendazole and quinine and evaluated microscopically 72 hrs post-
incubation. In addition, the colorimetric markers resazurin, CellTiter-Glo® and Vybrant® were tested as an alternative
assay read-out method.
Results: The chemical excystation method successfully induced E. caproni metacercariae to excyst at a rate of
about 20-60%. NEL remained viable in culture medium for 5–7 days. The results of an in vitro drug assay using NEL
mirrored the results of an assay using adult worms incubated with the same drugs. None of the markers could
reliably produce signals proportional to NEL viability or cytotoxicity without significant complications.
Conclusion: NEL are adequate for in vitro drug testing. Challenges remain in further improving the excystation
yield and the practicability of the assay setup. Resolving these issues could also improve read-outs using
colorimetric markers. Using NEL is in alignment with the 3 R rules of the ethical use of laboratory animals and can
greatly increase the rate and affordability with which drugs are screened in vitro against this intestinal trematode.
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ChemotherapyBackground
Echinostomiasis is a major food-borne intestinal trema-
todiasis caused by a number of Echinostoma species ac-
quired by the ingestion of uncooked freshwater fish,
crustaceans, snails or amphibians. It is a focal disease
found in Southeast Asia and the Far East usually in
poor rural areas and is associated with poor sanitary
conditions, poor economic conditions and malnutri-
tion [1]. Prevalence, Disability-Adjusted Life Years* Correspondence: jennifer.keiser@unibas.ch
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reproduction in any medium, provided the or(DALYs) and economic impact can be difficult to assess
due to the lack of quality surveys and reporting [2].
Recently, the first estimates on the burden of food-
borne trematodiases have been established and it has
been calculated that intestinal flukes overall contribute
to 83 699 DALYs [3]. Infections are most effectively
treated by praziquantel, administered at 10–25 mg/kg
body weight in a single oral dose [4,5].
E. caproni is a convenient model for studies on food-
borne trematodes. Its life-cycle is easy to maintain in the
laboratory, involving only a mouse as the definitive host
and Biomphalaria glabrata snails as the intermediatetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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can be conducted with relative ease, as mice can be infected
with 30 to almost 300 metacercariae and an adult infection
is established as soon as 2 weeks post-infection [6].
E. caproni can also be used as a pre-screening tool for
potential trematocidal compounds, though caution must be
applied, as E. caproni has different feeding habits and
niches in the definitive host as compared to other
trematodes [7].
Currently, in vitro drug testing with E. caproni is
conducted with the adult stage of the worm [8]. The
adult worms are incubated in the presence of candidate
drugs and monitored at selected time points. Their via-
bility is assessed via microscopic read-out, by observing
the morphology and motility of the worms. Though the
current E. caproni model is an effective drug discovery
tool, the in vitro screens using adult E. caproni worms
are disadvantageous in that they require the sacrifice of
mice, they yield a small quantity of worms and they are
time-consuming and expensive. An in vitro assay using
newly excysted larvae (NEL) would yield more worms
for testing, would be cheaper and faster and would be bet-
ter aligned with the 3Rs animal protection principles (re-
duce, replace, refine), by replacing adult worms obtained
from sacrificed mice, with NEL. Additionally, replacing
microscopic read-out with an automated read-out using
colorimetric markers could increase the efficiency and ob-
jectivity of the screens.
The aim of the present study was to develop an in vitro
drug sensitivity assay based on NEL. First, different param-
eters based on a previously described in vitro excystation
method were tested and optimized [9]. Second, NEL were
cultured in various media to determine optimal culturing
conditions. Subsequently, a NEL-based drug sensitivity
assay was set up and evaluated against the gold standard, a
drug sensitivity assay using adult E. caproni worms. In
addition, 3 colorimetric markers were tested in a NEL-
based assay as alternative read-out methods.
Methods
Drugs, chemicals and media
Praziquantel, quinine and albendazole were purchased from
Sigma-Aldrich (Buchs, Switzerland), and tribendimidine
was donated by the Shandong Xinhua Pharmaceutical
Company (Zibo, China). Drug stock solutions were made
by dissolving the compounds in DMSO (dimethyl sulfoxide,
Fluka, Buchs, Switzerland) at a concentration of 10 mg/ml
and were stored at −20°C until use.
RPMI 1640, Medium 199 (Med 199), Dulbeco’s modified
eagle medium (DMEM) and Minimum essential medium
(MEM) were purchased from Gibco (Basel, Switzerland).
Phosphate Buffer Solution (PBS), Amphotericin B (250 μg/
ml), penicillin-streptomycin (10 000 units penicillin and
10 mg/mL streptomycin), bile salts (B8756), trypsin10× solution (T4549) and L-cysteine (168149) were
purchased from Sigma-Aldrich (Buchs, Switzerland).
RPMI medium was put together as described by
Ingram and colleagues [10]. Locke’s 1:1 solution was pre-
pared according to studies conducted by Ursone and
Fried and adjusted to pH 7.4 [11]. Basch medium was
made as described previously [12].
The CellTiter-Glo® viability assay kit was purchased from
Promega and the Vybrant® Cytotoxicity Assay Kit was
purchased from Invitrogen, whereas the resazurin marker
was made by dissolving resazurin sodium salt (Sigma) in
1× PBS solution at a concentration of 125 mg/L. All
markers were stored at –20°C until use.
Parasites
The E. caproni life cycle was established at the Swiss
Tropical and Public Health Institute in 2004 and has
been maintained successfully since [6]. To obtain
metacercariae for excystation experiments, the shells of
infected snails were gently crushed and removed and a
mass of cysts was located at the pericardial region of the
snail. The cysts were sucked out and stored in Locke’s 1:1
solution in a 20 ml tube at 4°C until use.
Excystation of E. caproni metacercariae into newly
excysted larvae (NEL)
The excystation procedure used in this work was de-
rived from Saxton et al. [9]. Briefly, cysts were treated
with a trypsin-bile salt medium containing the reduc-
tant L-cysteine (hereon referred to as TBC medium).
Specifically, 15 mg trypsin and 40 mg bile salts were
diluted in 5 ml of NaCl/NaHCO3 solvent (8 g/L and
15 g/L respectively). In another tube, 40 mg of L-
cysteine was diluted in 5 ml of 0.05 M HCl solvent. The
two solutions were combined just before use and fil-
tered. Around 25 cysts were placed in a well-plate, 3 ml
of syringe-filtered TBC medium was added and the
setup was placed in a hot water bath at 40°C. After 1 hr,
the suspension was taken out, the number of excysted
larvae was counted and an excystation percentage (or
rate) was calculated. The TBC medium was removed
and Locke’s 1:1 solution was added.
Parameters affecting excystation rates
In order to maximize the excystation yield, experi-
ments testing various parameters of the TBC excy-
station method were performed. For each experiment,
the TBC excystation method was performed as
described above, varying one variable at a time. The
effects of the parameters were evaluated by calculating
the excystation rate. For each experiment described
below, values that are marked with * indicate the
values in the original TBC excystation method [9] and
thus served as control values.
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The cyst storage time affects cyst viability [13] and,
therefore, their excystation rate. The effect of cyst stor-
age time on their viability was monitored over 6 weeks.
The TBC excystation was applied on a sampling of the
cysts each week for up to 6 weeks. Storage medium was
changed once every 2 weeks. Cyst viability was deter-
mined on the basis of how many cysts excysted in each
treatment group. Due to frequent fungal contaminations
of the medium the effect of adding 2% Amphotericin B
solution to the storage medium was also tested.
Trypsin, bile salts and L-cysteine concentration
The effect of trypsin, bile salt and L-cysteine concentra-
tions in the TBC medium were assessed over a range of
concentrations: 0, 1, 1.5*, 3 and 5 mg/ml for trypsin, 0,
3, 4*, 5 and 7 mg/ml for bile salts and 0, 2, 4*, 8 and 40
for L-cysteine.
TBC medium pH, temperature and incubation time
In separate experiments, the optimal pH range of the
TBC medium, incubation temperature and incubation
time were determined. Cysts were incubated in TBC
medium at a pH of 7, 7.5, 7.8, 7.9, 8.0, 8.1, 8.2, 8.5 or 9.
The incubation temperatures tested were 35, 37, 38, 39,
40*, 41, 42, 43 and 45°C and the length of exposure to
TBC medium was tested at 1*, 1.5, 2, 2.5, 3, 4, 6 and
24 hrs.
Cyst number and volume of TBC medium
The effect of varying the amount TBC medium added
(1, 2, 3*, 4, 5 and 10 ml) as well as the cyst amount (25*,
40, 60, 80 and 100 cysts) was elucidated.
Acid-pepsin pre-treatment
Other species of echinostomes require an acid-pepsin
pre-treatment [14,15] and thus this was attempted here.
Cysts were incubated in 3 ml of an acid-pepsin solution
at 40°C for 2 hrs and then were treated with TBC medium
as described above. The excystation rate of these cysts was
compared to the excystation rate of cysts receiving only
an acid pre-treatment or no pre-treatment.
NEL culture conditions
The fitness of NEL in various culture media was tested. In
a 96-well plate, 20 larvae were placed in 200 μL of either
Locke’s 1:1 solution, RPMI, RPMI supplemented with 2%
glucose, Basch, MEM, DMEM, PBS 1× or Med 199. Incu-
bation tests in different media were conducted twice in
duplicate. The viability of the worms was assessed micro-
scopically at 24, 48, 72, 96 and 120 hrs using a viability
scale as follows: 0 = dead; 1 = both impaired movement
and markedly damaged tegument; 2 = slow movement or
notable damage to tegument; and 3 = lively movementand undamaged tegument. Worms were scored individu-
ally and the scores averaged. Due to frequent fungal
contaminations, the effect of adding 2% Amphotericin B
solution to the culture medium was also tested.
Drug assay with NEL
Four drugs were chosen for the assay: praziquantel,
tribendimidine, albendazole and quinine. Praziquantel is
the standard drug against echinostomiasis, tribendimidine
has shown good activity against E. caproni in vitro and
in vivo [8], albendazole has previously been recommended
for use [4] and quinine should not be effective and thus
served as a negative control.
A serial dilution was prepared in a 96-well plate at
concentrations of 30, 10, 3.3 1.1 and 0.37 μg/ml for
tribendimidine, albendazole and quinine and at concentra-
tions of 10, 3.3, 1.1, 0.37 and 0.12 μg/ml for praziquantel
(due to previous observations of its high activity). The cul-
ture medium used was RPMI supplemented with 5% glu-
cose and 1% penicillin/streptomycin mixture. Control
wells consisted of culture medium with 1% DMSO. Drug
dilutions were made in duplicate with a total volume of
200 μl, after which 50 μl of medium containing about
twenty larvae were added per well. All experiments were
conducted twice in duplicate.
The plate was read microscopically at 24, 48 and
72 hrs and the worms were scored according to the via-
bility scale described above. After 72 hrs, NEL from the
highest drug concentration wells were sampled and placed
on a glass slide for microscopic observation. Microscopy
was conducted using a Leica DM500B upright microscope
(Solms, Germany) and images were taken using a Leica
Application Suite camera and software (Solms, Germany).
Drug assay with adult E. caproni worms
In order to compare results of the NEL assay to the
current standard, a drug sensitivity assay was set up
using adult worms and the same drugs and drug stock
solutions. Adult E. caproni worms were obtained from
dissected intestines of infected mice and were cultured
in Med 199 supplemented with 1.5% glucose and 1%
penicillin/streptomycin mixture. A serial dilution of the
drugs was prepared in a 24-well plate at concentrations
of 90, 30, 10, 3.3 and 1.1 μg/ml for tribendimidine,
albendazole and quinine and of 30, 10, 3.3, 1.1 and
0.37 μg/ml for praziquantel. The total volume in each well
was 2 ml. Control wells consisted of culture medium with
1% DMSO. Two worms were added per well and each
drug was tested in duplicate. In total, 2 trials of 2 duplicates
were performed. The plate was then read microscopically
at 24, 48 and 72 hrs and the worms were scored according
to the same viability scale used for NEL. At 72 hrs, worms
in the wells containing 30 μg/ml of drug were observed
using a Zeiss upright microscope (Oberkochen, Germany)
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camera (Tokyo, Japan).
Colorimetric viability markers
Three colorimetric viability/cytotoxicity markers were
assessed for their use in an NEL-based assay: resazurin,
the CellTiter-Glo® Luminescent Viability Assay and the
Vybrant® Cytotoxicity Assay Kit. Resazurin is a fluores-
cent viability marker measuring intracellular reducing
capacity that has previously been successfully implemented
in drug sensitivity screens against Trypanosoma gambiense
and Trypanosoma rhodesiense [16] and with some success
in screens against Schistosoma mansoni [17]. CellTiter-Glo®
is a luminescent viability marker that measures intracellular
ATP activity upon cell lysis and the Vybrant® cytotox-
icity assay is a fluorescent assay that indirectly measures
cell cytotoxicity by reacting with glucose 6-phosphate
dehydrogenase (G6PD) that is released in the medium
from dying cells.
An assay measuring the signal correlation to NEL
number, as well as the optimal incubation time with the
marker was set up for each of the 3 markers. For
resazurin and CellTiter-Glo®, 20, 40, 60, 80 or 100 viable
NEL were placed in duplicate wells in a 96-well plate
topped up with up to 100 μl culture medium for
CellTiter-Glo® and 200 μl culture medium for resazurin.
Controls included 2 wells with medium only, 2 wells
with 100 unexcysted metacercariae and 2 wells with 100
dead NEL. Dead NEL were killed by incubating the NEL
overnight in culture medium containing 25% DMSO,
then rinsing the suspension with culture medium. In the
case of resazurin, 25 μl of resazurin solution was added
to each well, incubated for 10 min and automatic read-
outs were conducted at 10, 20, 30, 40, 50 and 60 min,
and 2, 3, 4, 6 and 24 hrs. In the case of CellTiter-Glo®,
100 μl CellTiter-Glo® reagent was added and the assay
was incubated for 10 min, then read at 10, 20, 30, 40, 50
and 60 min and 1.5 and 2 hrs. Vybrant® is a marker that
measures cytotoxicity (cell death) rather than viability,
thus 20, 40, 60, 80 and 100 dead (rather than viable)
NEL were measured and 100 live NEL served as con-
trols. The NEL were killed using the same method de-
scribed above. The wells were topped up to 200 μl
culture medium and subsequently 50 μl Vybrant® was
added. The assay was incubated for 10 min and mea-
surements were taken at 10, 20, 30, 40, 50, 60 min and
2, 3, 4, 6 and 24 hrs. All measurements were performed
using the SpectraMax M2 plate reader (Molecular De-
vices, Sunnyvale, USA) and the corresponding SoftMax
Pro® software.
Statistics
Averages and standard deviations were calculated with
Microsoft Office Excel 2003 or 2010. All graphs weregenerated in the same program. Additionally, a p-value,
for significant difference between viability of cysts stored
in Locke’s 1:1 versus Locke’s 1:1 supplemented with 2%
Amphotericin B, was calculated using the student’s
t-test, also using Microsoft Office Excel 2003 (unpaired,
2-tailed, assuming equal variance). The IC50 values and
their corresponding r values of the NEL and adult drug
sensitivity assays were calculated based on the median-
effect principle using CompuSyn® software (ComboSyn
Inc., 2007) [18]. The r-value represents the linear
correlation coefficient and is a measurement of goodness
of fit.Ethical approval
The work with E. caproni infected mice was approved
by the veterinary authorities of the Canton Basel-Stadt
(permit no. 2070) based on Swiss cantonal and national
regulations.Results
Parameters affecting excystation rates
The excystation rate of cysts stored in Locke’s 1:1 at 4°C
remained at an average of 23.1 -25.7% for 3 weeks, after
which it declined to 17.1% (± 2.4), 7.1% (± 5.7) and
4.0% (± 5.2) at 4, 5 and 6 weeks respectively. Moreover,
the addition of 2% Amphotericin B to the storage
medium significantly impaired excystation (t16 = 3.294,
p = 0.005).
Varying the trypsin, bile salts and L-cysteine concen-
trations did not affect excystation rates, except that
treatments where trypsin, bile salts or L-cysteine were
omitted resulted in no excystation. Additionally, an ex-
cess of L-cysteine (40 mg/ml) also inhibited excystation.
The effects of temperature and pH of the TBC
medium followed a bell curve. Excystation percentages
were optimal at incubation temperatures of 39–41°C. At
35°C, no larvae excysted and at 45°C, although a min-
imal amount excysted, the NEL were damaged and im-
paired. Meanwhile, optimal excystment occurred at
pH 7.8-8.2 in one trial, and at pH >7.8 in another trial.
A longer exposure time of the cysts to the TBC
medium resulted in higher excystation rates. Excystation
rates were stable at exposure times of 1–3 hrs, and
started to markedly increase at 4 hrs. However, the long
incubation time was detrimental to excysted larvae.
Thus, an incubation time of 1.5-2.5 hrs was determined
optimal, as longer incubation times started to negatively
affect larval viability.
Finally, a variety of parameters showed no effect on
metacercarial excystment. These include: the number of
cysts added to the TBC medium, the volume of TBC
medium applied to the cysts and pre-treatment of the
cysts in an acid-only or an acid-pepsin solution.
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NEL remained viable for 5 days in Basch, Med 199,
RPMI and RPMI with 2% glucose, whereas their viability
declined moderately in Locke’s solution and sharply in
PBS, MEM and DMEM (Figure 1). RPMI with 2% glu-
cose performed slightly better than Basch, Med 199 and
RPMI (though not significantly) and undocumented ob-
servations indicated that these larvae also often
remained viable for up to 7 days.
NEL drug sensitivity assay
IC50 values of praziquantel, tribendimidine, albendazole
and quinine at 72 hrs post-exposure are presented in
Table 1. Praziquantel and tribendimidine were highly ac-
tive against NEL in that they were lethal within 24 hrs at
a concentration of 30 μg/ml and that they both exhibited
low IC50 values. Albendazole also exhibited a low IC50,
however, it was much slower acting, showing an effect
only after 72 hrs at the highest concentration. As
expected, quinine had no effect and thus an IC50 value
could not be calculated.
The morphological effects of these compounds at the
highest concentration (30 μg/ml) were visualized at
72 hrs post-exposure and are shown in Figure 2.
Praziquantel caused severe tegumental damage and curl-
ing. Tribendimidine caused no visible tegumental dam-
age, but rather a flattening of the larvae, perhaps due to
paralysis. Albendazole caused slight distortions to the
larval body, but its major impact was a reduction in mo-
tility. Quinine had no effect on the larval morphology or
motility.
Adult drug sensitivity assay
Table 1 shows the derived IC50 values from the adult
worm assay at 72 hrs post-exposure. As in the NEL-
based assay, praziquantel and tribendimidine presented
low IC50 values, though the IC50 for tribendimidine was
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Figure 1 Newly excysted larvae (NEL) incubated over time in various culBoth of these compounds were highly active at 30 μg/ml
within 24 hrs of exposure.
Similarly as carried out with the NEL, adult worms
were imaged after 72 hrs of drug exposure at 30 μg/ml
(Figure 3). The morphological effects of the drugs on adult
worms were parallel to effects on NEL. Praziquantel caused
severe tegument damage and curling. Tribendimidine had
a paralyzing effect, where the worms were flattened but
with minimal or no damage to the tegument. The main
effect of albendazole was a decrease in the motility of
the worm at 72 hrs, though in some worms, a small




Fluorescence emissions (with background emission sub-
tracted) of NEL incubated with resazurin reached a
range of 516.7 (±183.0) to 737.3 (±156.9) at 10 min but
failed to show a linear correlation to NEL number. After
20 min incubation time the signal dropped to below 0
and only increased marginally for all measurements up
to 6 hrs of incubation. Furthermore, the signal did not
correlate with the number of viable NEL per well and
the signal from dead NEL was comparable. At 24 hrs in-
cubation time, the signal levels were higher (range: 467.5
(± 88.3) at 20 NEL/well to 1720.0 ± 165.4 at 80 NEL/
well) and reached a plateau at 60 NEL/well. Moreover,
the signal from dead NEL was comparatively lower that
that of live NEL (374.8 ± 195.2). However, at 24 hrs incu-
bation time, the signal from the cyst only wells was high
(1250 ± 18.3).
CellTiter-Glo® viability assay
Despite initial promising results, incubation of live NEL
with CellTiter-Glo® failed to consistently produce a strong
signal to NEL number correlation. The signal curves fluc-










ture media. Experiments are based on 2 trials performed in duplicate.
Table 1 IC50 values of Newly excysted larvae (NEL) and
adult E. caproni following treatment with praziquantel,
tribendimidine, albendazole and quinine
Drug NEL assay Adult worm assay
IC50 (μg/ml) R- value IC50 (μg/ml) R- value
Praziquantel 0.19 0.94 0.06 0.77
Tribendimidine 0.35 0.93 2.93 0.91
Albendazole 2.03 0.99 26.71 0.82
Quinine n.d. n.d. n.d. n.d.
IC50 values were calculated 72 hrs post exposure. R-value represents the
goodness of fit. N.d. means the data for that drug did not produce a curve
from which an IC50 value could be derived.
Panic et al. Parasites & Vectors 2013, 6:237 Page 6 of 9
http://www.parasitesandvectors.com/content/6/1/237the sensitivity of the reads (from1 read/well to 20 reads/
well) on the SoftMax Pro® greatly diminished the between-
read variation. Additionally, the signals generated from 100
dead NEL and 100 cysts were highly variable between
measurements, sometimes producing a negligible signal







Figure 2 Morphological effects of praziquantel, tribendimidine, alben
after 72 hrs of exposure to (A) praziquantel (B) tribendimidine, (C) albenda
tribendimidine, albendazole and quinine and 10 μg/ml for praziquantel. Im
surrounding the NEL in the albendazole image are an artifact due to the N
(F) shows a NEL from the control well and an empty metacercarial shell.Vybrant ® cytotoxicity assay
The fluorescence signals (background subtracted) of
Vybrant® positively correlated with the number of dead
NEL (R2 = 0.98) and reached a signal peak at 4 hrs, after
which the signal levels continued to increase but the lin-
earity of the curve started to decline. The signal plat-
eaued at 80 NEL/well (6441.3 ± 0.5). However, the signal
generated from 100 live NEL (1808.1 ± 951.8) was com-
parable to that of 40 dead NEL (2374.0 ± 615.5) and the
signal generated from 100 cysts (4675.7 ± 312.4) was
close to that of 60 dead NEL (4305.7 ± 1587.5).
Discussion
Echinostomiasis may not always exhibit widespread na-
tional prevalence in endemic nations, however, local
prevalence can be high, up to 65% in some areas [19].
Additionally, it is a stubbornly persistent disease due to
continued consumption practices of uncooked fresh-
water fish, crustaceans or amphibians, socio-economic






dazole and quinine on Newly excysted larvae (NEL). Pictures taken
zole and (D) quinine, at a concentration of 30 μg/ml for
age (E) shows a healthy NEL cultured in medium only. The bubbles
EL being pressed by the glass slip and not due to drug effect. Figure
(A)










Figure 3 Morphological effects of praziquantel, tribendimidine, albendazole and quinine on adult E. caproni. Worms were incubated for
72 hrs with 30 μg/ml (A) praziquantel, (C) tribendimidine, (D) albendazole, (E) quinine or (F) medium only. The dots in (D) are eggs that were
excreted by the adult worm. Figure (B) shows a portion of the adult worm from (A), zoomed in 2× to show the “blebbing” caused by
praziquantel more visibly.
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yet the reliance on only the broad-spectrum praziquan-
tel as the sole treatment for echinostomiasis is ill-
advised and the discovery of new active compounds is
imperative [5,19]. Due to its convenient life-cycle main-
tenance and similarity to other intestinal food borne
trematodes, E. caproni is a useful model for studies on
intestinal food-borne trematodiasis [6]. In vitro drug
sensitivity assays using adult E. caproni are effective, but
are low-throughput, time-consuming and the required
use of mice is expensive and ethically questionable. The
aim of this study was to develop an effective in vitro
drug sensitivity assay using NEL of E. caproni.
The first step was to test key parameters of the TBC
excystation method. Optimal conditions for good ex-
cystation yields are summarized in Table 2, as determined
by experiments in this study.Excystation rates were not affected in a dose-dependent
manner by the concentrations of trypsin, bile salts or L-
cystein, nor by the amount of TBC added or the number
of cysts present in the TBC medium. Previous morpho-
logical studies show that the TBC medium marginally
softens the shell of the metacercariae, but it is more so
that the trypsin and bile salts, as well as the alkaline pH
and warm temperature, are a trigger for the metacercariae
to release enzymes that digest the shell from the inside
[20]. Perhaps due to this latter point, we observe that the
excystation rates are not exactly dose-dependent, but ra-
ther a threshold presence of trypsin and bile salt (as well
as L-cysteine) is important.
In this study, it was shown that cysts stored in Locke’s
1:1 solution at 4°C should be kept no longer than 4 weeks,
after which their viability significantly declines. This is in
contrast to previous publications which allude that cysts
Table 2 Key factors for good (20–60%) excystation yields
Excystation factor Optimal values
Cyst storage time 0–4 weeks
TBC medium:
Trypsin concentration 1–5 mg/ml
Bile salts concentration 3–7 mg/ml
L-cysteine concentration 2–8 mg/ml
Amount of TBC medium ≥ 3 ml
Amount of cysts exposed to medium No optimum
pH of TBC medium 7.8–8.2
Incubation temperature 39–41°C
Incubation time 1–2.5 hrs
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post extraction [13]. Long storage times also make the cyst
suspension more prone to fungal contaminations. The
addition of 2% Amphotericin B to the medium did not
resolve the matter because of its negative effect on meta-
cercarial viability. However, unpublished observations in-
dicate that filtering the Locke’s solution prior to use and
changing the medium once a week almost eliminates the
risk of contamination.
Other attempts to increase excystation rates failed. An
acid-pepsin pre-treatment did not improve the excystation
rate, but did not damage it either. Acid-pepsin accelerates
excystation in the trematode Clonorchis sinensis as well as
in other helminths [15,21]. However, this was not the case
for E. caproni, suggesting that perhaps in vivo it is not a
trigger either.
Throughout this study, excystation rates did not
exceed an average of 60% (save for occasional outliers).
This is in contrast to published rates of 50-100%
[9,20,22]. There are several possibilities for this discrep-
ancy. The first is that the composition of trypsin or the
bile salts could play a role. Saxton et al. (2008), revealed
that having to switch suppliers for trypsin and bile salts
resulted in a significant drop in excystation rates, though
this was remedied by the addition of L-cystein to their
protocol [9,22]. Bile is not a homogenous and standard-
ized mixture, containing a variety of bile acids in varying
compositions. Moreover, some excystation publications
for other helminths revealed that the bile salt source did
in fact affect their excystation rates: for example, the use
of cattle-derived bile salts versus the use of sheep-
derived bile salts [22,23]. Other variations may entail
the use of different reductants such as 0.02 M sodium
dithionite [24] or simply a pre-treatment with only the
reductant [25]. Applying a reductant has also been
carried out in between an acid-pepsin pre-treatment
and an alkaline trypsin-bile salt pre-treatment for other
helminths [26].The ability of NEL to survive for 5 days in 200 μl cul-
ture medium in a 96-well plate and the simplicity of
their viability assessment facilitate their use in drug sen-
sitivity assays. NEL can be incubated at a temperature of
37°C, 5% CO2, in supplemented RPMI, Basch medium
or Med 199.
Drug sensitivity assays using NEL incubated with
praziquantel, tribendimidine, albendazole and quinine
showed parallel results to adult worm assays. That is,
praziquantel and tribendimidine were highly effective
drugs against both stages, whereas albendazole was less
effective and quinine was not effective at all. NEL are
slightly more sensitive to the compounds, as indicated in
Table 1. First, praziquantel and tribendimidine were
highly effective against both stages of the worm, how-
ever, whereas they were not completely lethal to adult
worms at a concentration of 30 μg/ml, at the same con-
centration, they were almost immediately lethal to NEL.
Furthermore, although praziquantel and tribendimidine
had similar IC50 values in NEL assays as in adult worm
assays, the IC50 for tribendimidine in adult worms was
higher. NEL were also far more sensitive to albendazole
after 72 hrs, as opposed to adult worms whose viability
was only reduced by a half at this time-point. This trend,
where the larval stage is slightly more sensitive to drug
effects than the adult stage, has also been observed for
other helminths: L1 larvae of T. muris are more sensitive
than the adult worms [27] and NTS of S. mansoni are
mostly more sensitive than the adult S. mansoni [12]. The
increased sensitivity of NEL renders them a favorable
compound pre-screening tool in drug screening cascades,
as compounds screened first on NEL are unlikely to pro-
duce false negatives.
Due to the slow and sometimes subjective nature of
the microscopic read-out, an automated method using
colorimetric markers would be a positive step forward
towards developing a high-throughput drug-screening
assay. However, none of the markers tested were adequate
for use in an NEL drug sensitivity assay. CellTiter-Glo®
failed to consistently produce a strong signal to NEL num-
ber curve. Resazurin produced a good signal to NEL num-
ber curve only after a long incubation time of 24 hrs but
cyst-only control wells also produced high signals.
Vybrant® did produce a good curve with a short incuba-
tion time of 4 hrs and a plateau was achieved at 80 NEL
per well. However, here too, wells containing cysts only
also produced a high signal. This is problematic as the
excystation procedure does not trigger 100% of the
metacercariae to excyst and currently, there is no practical
way to separate cysts from NEL. Until we can do that,
markers producing signals from cysts are not a consider-
ation for use in drug sensitivity tests with NEL. Nonethe-
less, the observation that incubation with both resazurin
and Vybrant® yielded high fluorescence signals from cysts
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reducing activity in the cysts. It is worth noting that in
order to place exact numbers of NEL for these assays, the
larvae have to be manually counted in, as currently there
is no short-hand method of determining their concentra-
tion to an exactitude that marker assays require. This is
not only time consuming but it also makes for a non-
sterile set-up, which can interfere with marker signals.
Thus, it is likely that this issue would have to be resolved
before further testing with markers can ensue.
Conclusion
Here we have presented an alternative to the adult
E. caproni drug sensitivity assay. The use of NEL instead
of adult worms is faster, cheaper, higher throughput and
more ethical. The results from the NEL and adult in vitro
assays are highly comparable. NEL are even slightly more
sensitive to the test compounds. This latter point makes
an NEL-based assay an attractive pre-screening tool, as it
would be unlikely to yield false negatives and therefore un-
likely to reject active compounds in the screening cascade.
Nonetheless, improvements to the assay should be
investigated. The excystation rates of the E. caproni
metacercariae could be ameliorated. Furthermore, prac-
ticalities in assay set up, especially in separating cysts
from NEL and accurately determining NEL concentra-
tion in a solution should be improved. Finally, in order
to increase its potential as a high-throughput assay, fur-
ther automated read-out methods should be researched.
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